Olema Pharmaceuticals, Inc. OLMA Change in AP
Change in AP at other companies
Other financials
Where this comes from
Reported directly by Olema Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.
The official record: Olema Pharmaceuticals, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Olema Pharmaceuticals, Inc.'s change in ap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Olema Pharmaceuticals, Inc.'s change in AP?
- Olema Pharmaceuticals, Inc. (OLMA) reported change in AP of -$5.68M in Q1 2026.
- How has Olema Pharmaceuticals, Inc.'s change in AP changed year-over-year?
- Olema Pharmaceuticals, Inc.'s change in AP decreased by 31.8% year-over-year, from -$4.31M to -$5.68M.
- What does change in AP mean?
- Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.